TENOFOVIR-EMTRICITABINE-(300+200)-DUOPETSA
- Where we areCL 86A BIS 15 22, CHAPINERO, BOGOTÁ
- Advice on WhatsAppMessage us at +573172701347
Description
This product requires a medical prescription
* Visual reference image to avoid errors in purchasing and dispensing.
IT IS A MEDICINE. DO NOT EXCEED THE RECOMMENDED USE. READ THE INDICATIONS AND CONTRAINDICATIONS. IF SYMPTOMS PERSIST, CONSULT A DOCTOR.
Route of administration: Oral.
The medicine Tenofovir-Emtricitabine, with doses of 300 mg of tenofovir and 200 mg of emtricitabine in a combined formulation, known as "DUOPETSA," is a combination of antiretroviral medicines used to treat and prevent infection with the human immunodeficiency virus (HIV). This combination of medicines is used in different contexts:
- HIV treatment: DUOPETSA is prescribed as part of antiretroviral therapy (ART) in patients who have already been diagnosed with HIV. Antiretroviral therapy aims to suppress HIV replication in the body, reduce the viral load to undetectable levels and improve immune function. This helps prevent disease progression and maintain good long-term health in people with HIV.
- Prevention of HIV transmission: In some cases, DUOPETSA is also used as a preventive measure in HIV-negative people at high risk of contracting HIV, in what is known as pre-exposure prophylaxis (PrEP). Taken regularly and as medically directed, DUOPETSA can help reduce the risk of acquiring HIV infection in individuals at risk.
The combination of tenofovir and emtricitabine is effective in suppressing HIV, as it acts as nucleoside analog reverse transcriptase inhibitors (NRTIs), blocking HIV replication inside human cells.
It is important to note that the prescription and use of DUOPETSA must be supervised by a physician specialized in infectious diseases or HIV/AIDS. Strict adherence to medical instructions is essential to ensure the effectiveness of treatment or prevention and to reduce the risk of side effects.